» Articles » PMID: 27442891

Cellular Elimination of Nanoparticles

Overview
Date 2016 Jul 22
PMID 27442891
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Exposure of the general population to nanoparticles (NPs) occurs mainly by dermal and oral uptake of consumer products, food and pharmaceutical applications and by inhalation. While cellular uptake mechanisms have been intensely studied it is less well known how NPs are eliminated from the cells. Quantification of the amount of excreted particles is complicated by inherent limitations of the technologies that are suitable to study excretion. Among the mechanisms to decrease intracellular particle concentration active excretion by lysosomal exocytosis appears to be the most important. Lysosomal localization, small particle size and high intracellular and low extracellular particle levels facilitate exocytosis. Transporting epithelia, cells with secretory function and highly proliferative cells are expected to be able to decrease intracellular particle concentrations more efficiently than cells lacking these characteristics. As NPs can influence the extent of exocytosis it is possible that NPs can stimulate their excretion.

Citing Articles

Latest developments in biomaterial interfaces and drug delivery: challenges, innovations, and future outlook.

Patel S, Salaman S, Kapoor D, Yadav R, Sharma S Z Naturforsch C J Biosci. 2024; .

PMID: 39566511 DOI: 10.1515/znc-2024-0208.


Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis.

Li Y, Yang P, Meng R, Xu S, Zhou L, Qian K Acta Pharm Sin B. 2024; 14(3):1380-1399.

PMID: 38486986 PMC: 10935063. DOI: 10.1016/j.apsb.2023.10.009.


Exocytosis of Nanoparticles: A Comprehensive Review.

Liu J, Liu Y, Li C, Cao A, Wang H Nanomaterials (Basel). 2023; 13(15).

PMID: 37570533 PMC: 10421347. DOI: 10.3390/nano13152215.


Live Cell Imaging by Förster Resonance Energy Transfer Fluorescence to Study Trafficking of PLGA Nanoparticles and the Release of a Loaded Peptide in Dendritic Cells.

Liu M, Lau C, Cabello I, Garssen J, Willemsen L, Hennink W Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375766 PMC: 10304224. DOI: 10.3390/ph16060818.


All-stage targeted therapy for the brain metastasis from triple-negative breast cancer.

Luo Z, Wu S, Zhou J, Xu W, Xu Q, Lu L Acta Pharm Sin B. 2023; 13(1):359-371.

PMID: 36815053 PMC: 9939358. DOI: 10.1016/j.apsb.2022.03.026.